Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 06, 2025 Initiated Phase 1 single-ascending dose/multiple-ascending dose (SAD/MAD) study with M4 positive allosteric modulator (PAM) NMRA-861, with data expected in the first quarter of 2026 Announces prioritization of obesity as lead indication for NMRA-215, a highly brain-penetrant NLRP3 inhibitor, with […]

Latham Group, Inc. to Participate at Upcoming Conferences in August 2025 GlobeNewswire August 06, 2025 LATHAM, N.Y., Aug. 06, 2025 (GLOBE NEWSWIRE) — Latham Group, Inc. (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will attend the following investor conferences:

Potbelly Corporation Reports Results for Second Fiscal Quarter 2025 GlobeNewswire August 06, 2025 Second quarter system-wide sales growth of 6.7% including 3.2% company-operated same-store sales growth and positive traffic growth Eight shop openings and 54 additional franchise shop commitments in the second quarter Raises full-year guidance and introduces 3Q'25 guidance including positive same-store sales of

The Honest Company Reports Second Quarter 2025 Results GlobeNewswire August 06, 2025 Transformation Pillars Continue to Drive Profitability Improvement, Gross Margin Expansion and Revenue GrowthDelivers Net Income of $4 Million and Gross Margin of 40.4%, Expansion of 210 Basis PointsReaffirms Full Year 2025 Financial Outlook LOS ANGELES, Aug. 06, 2025 (GLOBE NEWSWIRE) — The Honest

Amplify Energy Announces Strategic Initiatives Update, Second Quarter 2025 Results, and Updated Full-Year 2025 Guidance GlobeNewswire August 06, 2025 HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today an update on its strategic initiatives, operating and financial results for the second quarter of 2025,

Remitly Reports Second Quarter 2025 Results Above Outlook and Raises Full Year 2025 Outlook GlobeNewswire August 06, 2025 Second quarter send volume up 40% and revenue up 34% year over year Second quarter net income was $6.5 million and Adjusted EBITDA was $64.0 million Board of Directors authorizes $200 million share repurchase program SEATTLE, Aug.

Open Lending Reports Second Quarter 2025 Financial Results GlobeNewswire August 06, 2025 AUSTIN, Texas, Aug. 06, 2025 (GLOBE NEWSWIRE) — Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions for financial institutions, today reported financial results for its second quarter ended June 30, 2025.

Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus GlobeNewswire August 06, 2025 – Data to date in single- and multiple-ascending dose cohorts of healthy participants demonstrate a four-day half-life for ABI-6250, supporting target daily oral dosing profile and dose-dependent elevations in biomarker of

HilleVax Reports Second Quarter 2025 Financial Results GlobeNewswire August 06, 2025 BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended June 30, 2025. Second Quarter Financial Results As of June 30, 2025 and December

Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements GlobeNewswire August 06, 2025 Record quarterly net product sales of $102.7 million achieved within two years of our XDEMVY(R) launch, an increase of 152% year over year Direct-To-Consumer campaign has activated new patients, expanded base and depth of prescribers and led to a meaningful